前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービス
文献複写のお申込み
JDreamⅢ複写サービスのご利用が初めての方
学術文献の全文複写をお取寄せ
JDreamⅢ複写サービスのご案内
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202202259049187985   整理番号：22A1023723

腫瘍壊死因子αおよびインターロイキン2をコードするアデノウイルスは免疫チェックポイント阻害剤難治性頭頸部癌における三次リンパ組織シグネチャを誘導する【JST・京大機械翻訳】

Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer
著者 (42件)：
Clubb James H. A.
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Clubb James H. A.
(2TILT Biotherapeutics Ltd, Helsinki, Finland)
, 
Clubb James H. A.
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Kudling Tatiana V.
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Kudling Tatiana V.
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Heinio Camilla
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Heinio Camilla
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Basnet Saru
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Basnet Saru
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Pakola Santeri
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Pakola Santeri
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Cervera Carrascon Victor
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Cervera Carrascon Victor
(2TILT Biotherapeutics Ltd, Helsinki, Finland)
, 
Cervera Carrascon Victor
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Santos Joao Manuel
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Santos Joao Manuel
(2TILT Biotherapeutics Ltd, Helsinki, Finland)
, 
Santos Joao Manuel
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Quixabeira Dafne C. A.
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Quixabeira Dafne C. A.
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Havunen Riikka
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Havunen Riikka
(2TILT Biotherapeutics Ltd, Helsinki, Finland)
, 
Havunen Riikka
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Sorsa Suvi
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Sorsa Suvi
(2TILT Biotherapeutics Ltd, Helsinki, Finland)
, 
Sorsa Suvi
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Zheng Vincent
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Zheng Vincent
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Salo Tuula
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Salo Tuula
(4Department of Oral and Maxillofacial Diseases, Clinicum, University of Helsinki, Helsinki, Finland)
, 
Salo Tuula
(5Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland)
, 
Salo Tuula
(6Oulu University Central Hospital, Oulu, Finland)
, 
Salo Tuula
(7Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland)
, 
Baeck Leif
(7Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland)
, 
Baeck Leif
(8Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki Head and Neck Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland)
, 
Aro Katri
(7Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland)
, 
Aro Katri
(8Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki Head and Neck Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland)
, 
Tulokas Sanni
(7Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland)
, 
Loimu Venla
(7Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland)
, 
Hemminki Akseli
(1Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland)
, 
Hemminki Akseli
(2TILT Biotherapeutics Ltd, Helsinki, Finland)
, 
Hemminki Akseli
(3Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland)
, 
Hemminki Akseli
(7Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland)

資料名：
Frontiers in Immunology (Web)  (Frontiers in Immunology (Web))

巻： 13  ページ： 794251  発行年： 2022年 
JST資料番号： U7074A  ISSN： 1664-3224  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： スイス (CHE)  言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。

Copyright (c) 2009 Japan Science and Technology Agency. All Rights Reserved

TOP

BOTTOM